Literature DB >> 4077362

Influence of a prostaglandin-inhibiting drug on muscle soreness after eccentric work.

H Kuipers, H A Keizer, F T Verstappen, D L Costill.   

Abstract

Since the time sequence of exercise-induced muscle soreness corresponds well with the time sequence of exercise-induced morphological changes in animal skeletal muscle, it has been suggested that muscle soreness is related to an inflammatory response. Prostaglandins are assumed to play a role in the inflammatory process. The influence of a cyclo-oxygenase-inhibiting drug (flurbiprofen) on the subjective symptoms of soreness and eventual structural changes was investigated in six male subjects. The subjects performed one concentric and two eccentric work bouts of 30 min at 80% of the individual maximal work load on the bicycle ergometer. Muscle biopsies taken before, immediately after, and 24 h after work were used to examine structural, ultrastructural changes as well as for assessment of glycogen content. Plasma levels of muscle enzymes and subjective soreness were determined at regular intervals. Eccentric work elicited muscle soreness in all subjects: however, the soreness was consistently less in the second eccentric trial. No significant enzyme release was noticed in any of the subjects, whereas ultrastructural changes were restricted to the mitochondria. No influence of flurbiprofen on subjective soreness was noticed. After both eccentric trials muscle glycogen was lower 24 h after work compared to the content immediately after work. The results suggest that eccentric exercise interferes with glycogen synthesis and that prostaglandins do not play a major role in exercise-induced muscle soreness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077362     DOI: 10.1055/s-2008-1025866

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  24 in total

Review 1.  Delayed onset muscle soreness : treatment strategies and performance factors.

Authors:  Karoline Cheung; Patria Hume; Linda Maxwell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Exercise-induced muscle damage from bench press exercise impairs arm cranking endurance performance.

Authors:  Gregory G Doncaster; Craig Twist
Journal:  Eur J Appl Physiol       Date:  2012-04-24       Impact factor: 3.078

3.  Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage.

Authors:  A E Donnelly; R J Maughan; P H Whiting
Journal:  Br J Sports Med       Date:  1990-09       Impact factor: 13.800

Review 4.  Exercise-induced muscle damage and adaptation.

Authors:  C B Ebbeling; P M Clarkson
Journal:  Sports Med       Date:  1989-04       Impact factor: 11.136

Review 5.  Metabolic consequences of exercise-induced muscle damage.

Authors:  Jason C Tee; Andrew N Bosch; Mike I Lambert
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

6.  Effect of whirlpool therapy on the signs and symptoms of delayed-onset muscle soreness.

Authors:  L A Kuligowski; S M Lephart; F P Giannantonio; R O Blanc
Journal:  J Athl Train       Date:  1998-07       Impact factor: 2.860

Review 7.  Mechanisms of exercise-induced muscle fibre injury.

Authors:  R B Armstrong; G L Warren; J A Warren
Journal:  Sports Med       Date:  1991-09       Impact factor: 11.136

8.  High energy phosphates and related compounds, glycogen levels and histology in the rat tibialis anterior muscle after forced lengthening and isometric exercise.

Authors:  J H van der Meulen; H Kuipers; F R Stassen; H A Keizer; G J van der Vusse
Journal:  Pflugers Arch       Date:  1992-03       Impact factor: 3.657

9.  Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage.

Authors:  A E Donnelly; K McCormick; R J Maughan; P H Whiting; P M Clarkson
Journal:  Br J Sports Med       Date:  1988-03       Impact factor: 13.800

10.  Efficacy of epicutaneous Diractin (ketoprofen in Transfersome gel) for the treatment of pain related to eccentric muscle contractions.

Authors:  Matthias Rother; Egbert J Seidel; Priscilla M Clarkson; Stefan Mazgareanu; Ulrich Vierl; Ilka Rother
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.